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Abstract
Background Generic preference-based measures are com-
monly used to estimate quality-adjusted life-years
(QALYs) to inform resource-allocation decisions. How-
ever, concerns have been raised that generic measures may
be inappropriate in palliative care.
Objective Our objective was to derive a health-state clas-
sification system that is amenable to valuation from the ten-
item Palliative Care Outcome Scale (POS), a widely used
patient-reported outcome measure in palliative care.
Methods The dimensional structure of the original POS
was assessed using factor analysis. Item performance was
assessed, using Rasch analysis and psychometric criteria, to
enable the selection of items that represent the dimensions
covered by the POS. Data from six studies of patients
receiving palliative care were combined (N = 1011) and
randomly split into two halves for development and vali-
dation. Analysis was undertaken on the development data,
and results were validated by repeating the analysis with
the validation dataset.
Results Following Rasch and factor analyses, a classifica-
tion system of seven items was derived. Each item had two
to three levels. Rasch threshold map helped identify a set of
14 plausible health states that can be used for the valuation
of the instrument to derive a preference-based index.
Conclusion Combining factor analysis and Rasch analysis
with psychometric criteria provides a valid method of
constructing a classification system for a palliative care-
specific preference-based measure. The next stage is to
obtain preference weights so the measure can be used in
economic evaluations in palliative care.
Key Points for Decision Makers
We propose a new palliative care health-state
classification system termed Palliative Care
Outcome Scale (POS)-E.
POS-E classifies palliative care states as a
combination of seven dimensions.
The dimensions are pain, other symptoms, anxiety,
depression, family anxiety, feeling good about
oneself and practical matters.
1 Introduction
Economic evaluations are performed to inform the allo-
cation of resources between competing healthcare inter-
ventions. A commonly used method is cost-utility analysis,
which compares interventions in terms of their cost per
quality-adjusted life-years (QALYs) gained. The QALY
combines life expectancy (in years) and quality of life
(QOL; expressed in the form of ‘health state values’) into a
single metric based on people’s preferences [1]. The QOL
portion is estimated by assigning a numerical value to each
health state experienced by a person on a scale ranging
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from 1 (equivalent to full health) to 0 (dead) [2]. A com-
mon way of estimating health-state values is to use a
‘generic’ preference-based measure (PBM) such as the
EuroQol five-dimensional questionnaire (EQ-5D) [3],
Health Utilities Index Mark 3 (HUI3) [4], or Short-Form
6-Dimensions (SF-6D) [5]. Each generic PBM, e.g. EQ-
5D, has a preference-based algorithm for assigning values
to each health state. These preference weights are obtained
by asking members of the general public to value the health
states using a choice-based valuation technique such as
standard gamble [6, 7] or time trade-off [6].
These generic PBMs are deemed appropriate for all
patients, irrespective of their medical condition, because
they concentrate on broad aspects of health-related QOL
(HRQoL). However, debate has focussed on the degree to
which the broad nature of these PBMs incorporates attri-
butes of HRQoL that are particularly relevant to specific
health conditions and health disciplines [8]. The estimation
of QALYs in palliative care is one such case.
Palliative care is ‘‘the active holistic care of patients
with advanced progressive disease, aimed at achieving the
best possible QoL for patients and families, through the
management of pain and other symptoms, as well as
provision of spiritual, psychological and social support;
which may be initiated early in the course of treatment
along with other curative treatments’’ [9]. In the discipline
of palliative care, there are concerns that generic PBMs
do not incorporate many aspects of HRQoL important to
patients receiving palliative care and rather are heavily
focused on function (e.g. mobility, self-care and usual
activities) [10–12]. This has led to proposals for the
development of a condition-specific PBM (CSPBM) that
would be appropriate for patients receiving palliative care
[10, 13]. Furthermore, the likely dominant nature of pal-
liative care needs in determining HRQoL arguably justi-
fies the development and use of a CSPBM in palliative
care. Presently, no such measure exists. The Palliative
Care Outcome Scale (POS) has been suggested as suit-
able for this purpose [10]. The POS is a validated pal-
liative care outcome measure [14] that has been used in
many studies, including randomized controlled trials
(RCTs) and observational studies, as well as for service
evaluation [15–22]. Given the dearth of economic evalu-
ations in palliative care [23], developing a CSPBM from a
widely accepted and commonly used instrument such as
the POS enables retrospective analysis of existing datasets
and increases the likelihood that the measure will be used
in future studies [24].
The process of developing a PBM from an existing
condition-specific outcome measure involves three stages
[8]. This paper reports on the first stage; the second and
third stages will be addressed in a separate paper.
2 Methods
2.1 Design
This study was a secondary analysis of baseline data from
several studies of patients receiving palliative care.
A health-state classification is a multidimensional
framework that can be used to define health states. Such
classifications define a set of health states by selecting one
level from each dimension. For example, the EQ-5D has
five dimensions, each comprising three levels of response,
and defines a total of 243 states (35). This presents a more
manageable number to value (and even then only a sample
of states were directly valued). The POS has ten items,
eight of which have five levels, and two items have three
levels each. Given the number of items and their corre-
sponding levels, the POS would define a practically
unmanageable number of 3,515,625 health states
(5 9 5 9 5 9 5 9 5 9 5 9 5 9 5 9 3 9 3). This would
result in unreasonable cognitive demands on respondents to
the valuation exercise required to estimate quality weights.
Therefore, the first stage of deriving a health-state classi-
fication that is amenable to valuation from an existing
measure involves using Rasch analysis to reduce the size of
the existing measure while minimizing the loss of
descriptive information [8]. This classification system
would be designed to capture the range of palliative care-
related problems that can occur with different diagnosis
with minimal loss of information and the ability to use the
responses from the original instrument to map onto it.
Although some studies have derived and valued health-
state classifications using standard methods (e.g. factorial
and orthogonal block designs) that do not require a
reduction in the size of the existing measure, such methods
are inefficient because they treat items as independent
(uncorrelated) statements and so are likely to result in
deriving (and valuing) implausible health states. It is
unlikely that the types of problems seen in palliative care
are unrelated (as is implied in orthogonal and factorial
designs). For example, it makes no sense to define a health
state where a person feels ‘good about themselves always’
but also feels ‘depressed always’ as they are both likely to
have the same primary cause. This approach of developing
a health-state classification by using Rasch to reduce a
larger instrument has been applied to numerous non-pref-
erence-based measures, including the SF-36 [25], SF-12
[26], menopausal health questionnaire [27], a preference-
based measure for atopic dermatitis [28], King’s Health
Questionnaire [29], Clinical Outcomes in Routine Evalu-
ation-Outcome Measure (CORE-OM) [30] and European
Organisation for Research and Treatment of Cancer
Quality of Life Questionnaire 30 (EORTC QLQ-C30) [31].
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This study used a four-stage process as recommended by
Brazier et al. [8] as follows:
1. Identify the most relevant dimensions of the POS for
use in the POS-E, giving an initial descriptive system.
2. Identify item response levels that could be removed
from the new descriptive system.
3. Identify item response levels that can be merged
without loss of information.
4. Validate the new instrument by repeating steps 1–3
above in a separate dataset.
2.2 Datasets
We merged the following baseline POS data from six
studies of patients receiving palliative care.
1. A cancer mortality follow-back survey (N = 596)
from 2009 to 2010 in London (The QUALYCARE
study) [32].
2. A study of Parkinson’s disease (longitudinal commu-
nity study of predictive factors; N = 82) [33].
3. An RCT on the effectiveness of an integrated palliative
and respiratory care service for patients with advanced
disease and refractory breathlessness in 2014 in the
UK (N = 105) [12].
4. A longitudinal study on trajectories of illness of stage 5
chronic renal disease in the UK (N = 74) [34].
5. A cross-sectional study on symptom burden and
palliative care needs in chronic obstructive pulmonary
disease and cancer in Germany (N = 109) [15].
6. A randomised phase II trial of dignity therapy in the
UK (N = 45) [35].
We then randomly split the data into a development
dataset (N = 504) and a validation dataset (N = 508),
providing suitable sample sizes for Rasch analysis. There is
evidence that some Rasch fit statistics for polytomous
instruments (e.g. POS) are sensitive to the sample size, and
larger samples can have a higher chance of type 1 errors
[36]. The development dataset was used to develop the
health classification, and this was validated by repeating
the analysis on the validation dataset. See the appendix
(Table 7) for the descriptive statistics for each dataset. All
datasets were anonymized prior to analysis.
2.3 The Palliative Care Outcome Scale (POS)
The ten-item POS is a short easy-to-use clinical outcome
measure originally developed and validated in eight end-
of-life and palliative care settings in the UK, including
hospital, community, inpatient hospice, outpatient, day
care and general practice [14, 37]. It was developed to
measure domains that impact on the QOL of patients
receiving palliative care. The questionnaire consists of ten
items, each item scored on a 5-point Likert scale ranging
from 0 to 4, except items 9 and 10 (‘time wasted’ and
‘practical matters’), both of which are scored on a 3-point
scale (0, 2 and 4) as shown in the Electronic Supplemen-
tary Material (ESM) 1. The POS has been well validated
and is widely used in clinical practice and research
regionally and nationally in the UK to evaluate and
improve the quality of care, and has been culturally
adapted for use in 20 EU countries, Africa and other
countries around the globe [15–22]. Two systematic
reviews (in 2011 [39] and 2015 [38]) on the use of the POS
found it was used in 78 published studies in both patients
with and without cancer.
2.4 Analysis
The objective of the analysis was to derive a multi-di-
mensional health-state classification system amenable to
valuation by reducing the number of items and item levels
in the POS.
2.4.1 Step 1: Establishing Dimensions
Principal component analysis (PCA) was used to assess the
dimensions of the POS. PCA is commonly used in the
development of new instruments to provide early indica-
tions of possible dimensions before Rasch analysis is
attempted [40]. First, the Kaiser–Meyer–Olkin (KMO)
measure of sampling adequacy was used to assess the
appropriateness of POS data for PCA (the KMO value
should be[0.5 if the data are appropriate) [41]. In addition,
Bartlett’s test of sphericity was used to test whether the
correlations between POS items were significant [42].
Significant factors (dimensions) were identified using
Horn’s parallel analysis [43] incorporated into an online
facility by Watkins [44]. Next, the rotated factor matrices
were examined to assess correlations of every item with
each of the main factors of the instrument. We used both
orthogonal and oblique rotation methods and compared the
results of both, as recommended in the literature [45]. In all
matrices, loadings with coefficients C|0.400| were consid-
ered to reveal strong correlations between an item and a
factor. Items loading on the same factor were considered to
belong to the same underlying dimension captured by the
POS.
2.4.2 Step 2: Eliminating Items Per Dimension
Rasch analysis was used to reduce the POS to a simpler
descriptive health-state classification system by identifying
POS items that did not fit the Rasch model and therefore
were potentially unsuitable for inclusion in the
Development of a Palliative Care-Specific Health Classification System 355
classification system. Rasch analysis is a mathematical
technique used to convert categorical data to continuous
data [46]. Rasch methods can be used to assess the extent
to which individual items represent the underlying con-
struct that an instrument intends to measure, thus enabling
the assessment of the appropriateness of items for a clas-
sification system.
The following criteria were considered for item exclu-
sion, in line with recommendations for multidimensional
measures [8]:
• Item-level ordering (disordered thresholds): we exam-
ined threshold maps to identify items that had disor-
dered thresholds. For instance, ordered thresholds
indicate that a person with a high level of an attribute,
such as pain, is more likely to endorse a high level on
an item that measures pain than is a person with less
pain. Disordered thresholds suggest that respondents
are unable to differentiate between adjacent item
categories [47]. In such instances, adjacent response
categories were merged to obtain ordered thresholds.
Items were excluded if their thresholds remained
disordered despite merging of adjacent response cate-
gories. Furthermore, if the only way to obtain an
ordered threshold for an item was by merging adjacent
response categories in a way that did not make clinical
sense, then such an item was eliminated. For example,
it was deemed clinically meaningless to merge response
categories ‘moderately’ and ‘severely’, as these indi-
cate significantly different levels of severity.
• Rasch goodness of fit: following threshold re-ordering,
overall and item-specific fit statistics were inspected to
assess the extent to which the entire instrument, as well
as individual items, fit the Rasch model. Items were
excluded if fit residuals were[2.5 or less than -2.5
and/or chi-squared statistics were significant at the
0.001 level after Bonferroni adjustment [8].
• Differential-item functioning (DIF): items that demon-
strate significant DIF are items with response patterns
that vary according to specific patient factors such as
diagnosis, age group, sex or ethnicity. Such items were
excluded from further consideration because DIF can
be a source of misfit in the Rasch model and because
items forming a PBM should ideally express the same
aspects of HRQoL across the whole patient population
(and not distinguish significantly among subgroups
with different baseline characteristics).
2.4.3 Step 3: Item Level Reduction
Rasch analysis can identify response levels that may be
merged without losing descriptive information, offering
further means of simplifying the classification system [8].
We identified potential item categories for merging by
examining Rasch category probability curves and response
frequencies. Visual inspection of respective category
probability curves determined which adjacent response
categories to merge. We also sought expert opinion about
the clinical and psychometric meaningfulness of the
merged item levels. These experts included a professor of
psychology (Dr. R. Siegert, Auckland University of
Technology, New Zealand) and two palliative care clini-
cians (Dr. P. Edmunds, King’s College Hospital, London,
and Dr. P. Kane, Beaumont Hospital, Dublin).
We also assessed the unidimensionality of the new clas-
sification system by using the test proposed by Smith [48],
which involves conducting paired t tests of the final models.
Unidimensionality is confirmed when B5% of the tests are
significant at the p\0.05 level [49]. We also examined the
person separation index (PSI) to assess how efficiently the
final set of items was able to separate those people measured.
PSI values range from 0.0 to 1, with higher values indicating
better separation and a more precise measure [49].
2.4.4 Step 4: Validation of Classification System
The health-state classification was validated by repeating
steps 1–3 of the analysis using the validation data. We
inspected the examining overall and item fit statistics, DIF,
unidimensionality and item–response combinations.
RUMM2020 was used for all Rasch analysis and
STATA version 12 for all other statistical analysis.
3 Results
3.1 Step 1: Factor Analysis
The KMO measure of sampling adequacy reached 0.79,
suggesting that factoring of data was appropriate and
meaningful. Bartlett’s test of sphericity demonstrated the
statistical significance of the findings (p\ 0.0001).
Although the analysis identified three factors with eigen-
values above 1, which explained 52% of the total variance
(see Table 8 in the appendix for details), Horn’s parallel
analysis indicated two significant factors (Table 1). The
scree plot (Fig. 1) appears to support a two-factor solution
as the slope of the line flattens after the second factor.
In line with results of parallel analysis, a two-factor
solution was extracted for rotation. Table 2 shows two
rotated factors, one comprising six items (primarily about
psychological and physical wellbeing) and the other com-
prising three items (two relating to the standard of care and
one relating to psychological wellbeing). One item (time
wasted) did not load above 0.40 on either of the two fac-
tors. Results were very similar between the two methods of
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rotation (orthogonal vs. oblique), with all the items loading
on the same components.
The results of PCA indicated that the POS consists of
two domains that are moderately correlated. These domains
do not appear to be consistent with predefined conceptual
domains of the POS. Our findings suggest that the POS
constitutes a measure with no clear multidimensionality.
Thus, it was deemed necessary to conduct Rasch analysis
on the whole instrument, rather than on any specific
domain, in the next stage of the analysis.
3.2 Steps 2 and 3: Use of Rasch Analysis and Expert
Opinion to Merge Categories, Eliminate Items
and Develop a Unidimensional Scale
3.2.1 Item-Level Ordering
A total of nine items (items 1, 2, 4, 5, 6, 7, 8, 9 and 10)
were disordered in the initial Rasch model. For two of the
nine disordered items (item 1 ‘pain’ and item 2 ‘other
symptoms’), ‘slightly’ and ‘moderately’ were collapsed
into a single category, as were ‘severely’ and ‘over-
whelmingly’, resulting in three categories per item. Simi-
larly, ‘family anxiety’, ‘shared feelings’, ‘depression’ and
‘feeling good’ (items 4, 6, 7 and 8, respectively) were
converted to three-level items by merging ‘occasionally’
with ‘sometimes’ into a single category and ‘most of the
time’ with ‘always’. Wasted time (item 9) and practical
matters (item 10), which have three levels in the original
questionnaire, were converted to two-level items by
merging ‘half a day’ with ‘more than half a day’ (item 9),
and ‘practical problems being addressed’ with ‘no practical
problems’ (item 10). The threshold probability curves for
item 5 (information) suggested that this item would only
work with two categories. Therefore, ‘full information’,
‘information given but hard to understand’, ‘information
given on request’ and ‘very little information given’ were
collapsed into a single category. However, because this
merging was not deemed to be clinically meaningful, item
5 was eliminated from further analysis.
3.2.2 Rasch Model Goodness of Fit
After all thresholds were ordered, we assessed goodness of
fit by examining overall and individual item statistics.
Table 1 Significant components of the Palliative Care Outcome Scale identified by principal component analysis (N = 504), and comparison of
components with eigenvalues[1 with significant components identified by Horn’s parallel analysis
Component PCA: initial eigenvalues Horn’s parallel analysis: significant mean eigenvalues (SD)
Total % of variance Cumulative %
1 2.908 29.080 32.807 1.2609 (0.0359)
2 1.269 12.693 41.773 1.1833 (0.0355)
3 1.013 10.128 51.901 1.1134 (0.0242)
Bold formatting indicates the significant eigenvalue levels identified using each approach
PCA principal component analysis, SD standard deviation
Fig. 1 Scree plot of principal component of POS items (N = 504)
Table 2 Rotated two-component matrix (orthogonal; N = 504)
POS items Component Conceptual domain of item
1 2
Anxiety 0.772 Psychological wellbeing
Depression 0.658 0.230 Psychological wellbeing
Family anxiety 0.644 –0.226 Psychological wellbeing
Pain 0.585 0.292 Physical
Symptoms 0.575 0.244 Physical
Feeling good 0.567 0.368 Psychological wellbeing
Time wasted 0.260 Quality of care
Information 0.737 Quality of care
Practical matters 0.640 Quality of care
Share feelings 0.525 Psychological wellbeing
Principal component analysis. Rotation: varimax with Kaiser nor-
malization. Bold formatting indicates loadings C|0.400|
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Initial overall fit statistics of the items indicated poor fit to
the Rasch model, with items 3, 5 and 6 showing misfit (a fit
residual beyond ±2.5 and a chi-squared probability sig-
nificant at the 0.001 level). Items 5 and 9 also exhibited
DIF. Results of the initial analysis on all items are shown in
Table 3. Based on the results of Rasch analysis, a number
of items were consecutively excluded from further analysis
according to our exclusion criteria until a good model fit
was achieved.
Successive Rasch analyses led to the exclusion of
items 5, 6 and 9 as they persistently had a poor fit to the
Rasch model. For example, item 5 (information) had the
poorest fit when compared with other items, it exhibited
DIF, and its thresholds could only be ordered by com-
bining adjacent levels in a way that was neither cogni-
tively nor clinically meaningful. Items were excluded
one at a time and both Rasch statistics and the PSI were
constantly checked. This resulted in a final scale con-
sisting of seven items (1, 2, 3, 4, 7, 8 and 10). With the
exception of item 10, all other items had three response
levels (e.g. ‘not at all’, ‘occasionally or sometimes’ and
‘most of the time or always’). Item 10 (which originally
had three levels) was collapsed to two levels: ‘no
problems or problems resolved’ and ‘problems in the
process of being resolved or problems exist’ (Table 4).
The scale demonstrated a good model fit (X2 probability
0.047). All items had a reasonable fit, as shown in
Table 5, and no DIF was observed. The PSI reached a
reasonable level of 0.678.
Figure 2 shows the threshold map with items arranged
in order of increasing difficulty from top to bottom, and
with severity levels increasing from left to right.
Table 3 Results of initial
Rasch analysis of Palliative
Care Outcome Scale (POS)-E
(all items included)
Item Threshold Statistics after threshold re-ordering
Residuala X-square p valueb DIF
1 Pain Disordered –0.574 8.352 0.499 No
2 Other symptoms Disordered –1.410 21.811 0.010 No
3 Anxiety Ordered –3.254 40.843 0.000 No
4 Family anxiety Disordered –0.046 10.655 0.300 No
5 Information Disordered 3.442 46.423 0.000 Yes
6 Shared feelings Disordered 3.758 34.484 0.000 No
7 Depression Disordered –1.237 9.849 0.363 No
8 Feeling good Disordered –1.048 8.598 0.475 No
9 Time wasted Disordered 2.177 25.787 0.002 Yes
10 Practical matters Disordered 1.118 11.222 0.261 No
Overall model statistics after threshold re-
ordering
Total item X-square = 218.025;
p = 0.0000
Person-separation index: 0.657
All statistics showing item misfit into the Rasch model are presented in bold
DIF differential-item functioning
a Residuals[2.5 or\-2.5 are considered high
b p\ 0.01 indicates items that do not meet Rasch item fit criteria
Table 4 Items and levels in final Palliative Care Outcome Scale
(POS)-E scale
Item Categories Score
Family anxiety No, not at all 0
Occasionally/sometimes 1
Most of the time/always 2
Other symptoms No, not at all 0
Slightly/moderately 1
Severely/overwhelmingly 2
Pain No, not at all 0
Slightly/moderately 1
Severely/overwhelmingly 2
Depression No, not at all 0
Occasionally/sometimes 1
Most of the time/always 2
Anxiety No, not at all 0
Slightly/moderately 1
Severely/overwhelming 2
Practical matters Addressed 0
Not addressed 1
Feeling good Always/most of the time 0
Occasionally/sometimes 1
Not at all 2
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As shown in Fig. 3, the item map demonstrates that the
new instrument is well targeted to the study population as it is
able to capture the whole range of severity of palliative-care
symptoms, with minimal floor or ceiling effects and good
spread of items across the full range of respondents’ scores.
3.2.3 Deriving Plausible Health States From the POS-E
for Utility Measurement
The threshold map (Fig. 2) was used to derive plausible
health states. This map illustrates the most likely combi-
nations of item responses expected to be obtained by the
study population at various levels (locations) of symptom
severity. Items have been ordered from the easiest (item 4
‘family anxiety’) to the most difficult (item 8 ‘feeling
good’), as indicated by their average location in the Rasch
model. Shaded areas 0 (blue), 1 (red) and 2 (green) cor-
respond to the three levels ‘not at all’, ‘occasionally or
sometimes’ and ‘most of the time or always’, respectively,
with the exception of item 10, which has two levels: 0 (no
problems or problems resolved) and 1 (problems in the
process of being resolved or problems exist). The threshold
map allows prediction of the most likely responses at
various levels of severity. For example, a person whose
symptom severity corresponds to location 0 on the logit
scale is expected to most likely respond 0011112 (to items
8, 10, 3, 7, 1, 2, and 4, respectively).
Each combination of item responses represents a plau-
sible health state likely to be observed in people with
common palliative care problems. As illustrated in Table 6,
a total of 14 distinct health states can be identified.
The results of the test for unidimensionality proposed by
Smith [48] showed that the proportion of independent
t tests that were significant at the 0.05 level was 1.52%
(well below the 5% level), thus supporting the unidimen-
sionality of the classification system.
3.3 Step 4: Validation of the Classification System
The POS-Ewas validated on the validation sample (N = 508):
the scale had satisfactory overall and item fit statistics and no
DIF was observed. The post hoc unidimensionality test also
verified the scale’s unidimensionality in this sample, and the
threshold map indicated the same most likely item–response
combinations (reflecting plausible health states) with those
demonstrated by the analyses on the estimation sample. In total,
the POS-E describes 1458 health states.
4 Discussion
We describe the first stage in developing a health-state
classification for palliative care: the POS-E. Using rigorous
research methods [8], we have derived the POS-E
Table 5 Rasch statistics of the Palliative Care Outcome Scale (POS)-
E measure
Item Rasch analysis statistics
Residual X-square p value
1 Pain 0.452 5.586 0.694
2 Other symptoms –0.424 11.073 0.198
3 Anxiety –2.090 20.088 0.010
4 Family anxiety 1.221 11.423 0.179
7 Depression 0.247 10.893 0.208
8 Feeling good 1.084 6.422 0.600
10 Practical matters 2.951 9.339 0.315
Overall model statistics Total item X-square = 74.825; p = 0.0472
Person-separation index: 0.678
Fig. 2 Threshold map
illustrating plausible health
states obtained by Rasch
analysis. POS Palliative Care
Outcome Scale
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classification system from an existing palliative care
measure, the POS. The next stage of the research will
involve preference elicitation and related regression-based
statistical modelling to derive preference weights for all
health states described by the POS-E. This will result in a
CSPBM capable of generating QALYs for use in economic
evaluations in palliative care.
POS-E is a unidimensional seven-item scale able to
capture the full range of severity of palliative care needs.
Six of the items have three levels each, and one item
(measuring practical matters) has two levels. The PSI of
this scale was approximately 0.68, which is somewhat
lower than the 0.70 value generally considered accept-
able for group comparison [50]. Nevertheless, 0.68 was
deemed adequate for our purpose, given the ability of the
scale to discriminate amongst different respondent groups
needed to be traded off with its conciseness and conve-
nience in a valuation survey, wherein respondents need to
process a combination of individual statements rather than
a summated scale score.
One limitation of our approach, similar to the method-
ology proposed by Sugar et al. [51], is that the number of
generated health states is limited and does not capture the
whole range of plausible combinations of responses.
Despite generating a limited number of health states,
application of this approach allows for the valuation of all
potential health states described by the POS-E. An
advantage of Rasch analysis over the clustering-based
approach is that it assigns all potential health states (i.e. all
combinations of item responses including those not illus-
trated in threshold maps) to different locations along the
scale according to their level of severity. The relationship
between the location of the health states across the latent
variable and the respective utility values obtained in a
valuation exercise can be estimated and used to generate
utility values for all patients completing POS-E. This
Fig. 3 Item map of the
Palliative Care Outcome Scale
(POS)-E showing the
distribution of items across
respondents
Table 6 Health states (and
coverage) of the Palliative Care
Outcome Scale (POS)-E as
identified by the threshold map
Item Health states (N = 504)
1 2 3 4 5 6 7 8 9 10 11 12 13 14
4 Family anxiety 0 1 1 1 2 2 2 2 2 2 2 2 2 2
2 Other symptoms 0 0 1 1 1 1 1 1 1 1 2 2 2 2
1 Pain 0 0 0 0 0 0 1 1 1 2 2 2 2 2
7 Depression 0 0 0 0 0 1 1 1 1 1 1 1 2 2
3 Anxiety 0 0 0 1 1 1 1 1 1 1 1 1 1 2
10 Practical matters 0 0 0 0 0 0 0 1 1 1 1 1 1 1
8 Feeling good 0 0 0 0 0 0 0 0 1 1 1 2 2 2
Coverage (N) 40 79 13 49 17 8 128 35 14 13 27 14 21 46
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solution has been explored using regression techniques in a
subsequent application of this approach on the Flushing
questionnaire [52]. The findings of this latter study showed
it is possible to assign appropriate utility values to all
potential health states of a measure based on their location
along the latent variable as estimated by Rasch analysis.
However, it is conceivable that the Rasch approach we
used would be best suited to a unidimensional instrument.
Developing a CSPBM from an existing palliative care
measure has numerous advantages. Adapting a widely
accepted and commonly used instrument such as the POS
enables retrospective analysis of existing datasets and
increases the likelihood that the measure will be used in
future studies [24].
However, a major disadvantage of CSPBMs is that they
may be prone to focusing effects where the effect of the
condition is overrated because respondents to the valuation
survey focus solely on the areas of health included in the
classification system rather than viewing them in a broader
perspective. Another disadvantage of CSPBMs is the cor-
relation between perfect health and the best possible state
described by a classification system. It is conceivable that a
person could endorse the best possible health state based on a
specific instrument but still have other problems not covered
by its classification system. Thus, it becomes challenging to
compare results between different PBMs because ‘best
possible’ health states are instrument specific [8].
Nevertheless, these disadvantages are perhaps less cru-
cial when the condition of interest is the overriding factor
in determining HRQoL, as is likely to be the case for
patients receiving palliative or end-of-life care. Further-
more, because advanced life-limiting conditions affect
people’s HRQoL in a wide variety of ways, the POS-E
classification system covers a wider range of dimensions
than many other CSPBMs. The decision on whether to use
a CSPBM or a generic PBM will always involve a trade-off
between the pros and cons of CSPBMs relative to the
condition of interest [8]. In the case of palliative and end-
of-life care, the potential limitation of existing generic
measures [13], the wide range of the POS-E classification
system, and the likely dominant nature of palliative care
needs in determining HRQoL all favour the development
and use of a CSPBM. The argument in favour of CSPBMs
for palliative care is further strengthened by research
around the role of capabilities and wellbeing in end-of-life
care, which highlights that the objectives of end-of-life
care do not always focus solely on health but may also
include impacts on wellbeing [53]. This is particularly
evident in the development work for the ICECAP Sup-
portive Care Measure (ICECAP-SCM) [54], which is a
CSPBM that measures capability at the end of life for use
in economic evaluations. The POS-E relates to the
ICECAP-SCM in that both instruments seek to incorporate
important aspects of palliative and end-of-life care into
economic evaluations. Standard economic instruments
have been criticised for failing to do this [10, 11] However,
there are important differences between the two instru-
ments, mainly due to conceptual differences in their
respective evaluative frameworks. The POS-E measures
impact on health (or utility), whereas the ICECAP-SCM
gives more attention to broader impacts on capability and
wellbeing and is particularly important where health out-
comes are not the focus of evaluation, such as social care
interventions [55]. Nevertheless, because palliative and
end-of-life care include aspects of both health (e.g. pain)
and wellbeing (e.g. availability of social support), among
other things, the POS-E and ICECAP-SCM can be regar-
ded as complementary rather than mutually exclusive. Our
analysis is based on pooled data from six studies, which
was necessary to obtain a large enough sample to produce
reliable and representative estimates. However, because the
data were from patients with different types of cancer and
those without cancer, it is perhaps a reasonable reflection
of the diverse diagnoses of palliative care patients and
therefore arguably more generalizable.
5 Conclusion
This study has shown that reducing the POS to a health-
state classification system for palliative care (POS-E) is
possible and that the results are robust. The POS-E clas-
sifies palliative care states as a combination of seven items:
pain, other symptoms, anxiety, depression, family anxiety,
feeling good about oneself, and practical matters. We also
identified 14 plausible health states that can be used to
value the HRQoL of patients receiving palliative care.
6 Further Research
The next step for this study is to undertake a valuation
survey to attach appropriate utility values to all health
states of the POS-E and thus convert it into a preference-
based index. Our aim is that the new PBM will be suit-
able for cost-utility analyses of palliative care interventions
where the use of generic PBMs such as the EQ-5D has
been shown to be problematic [56–58]. Since this measure
has been derived from the POS, an instrument routinely
used for outcome monitoring in patients receiving pallia-
tive care in the UK and beyond, this study is expected to
enable wider assessment of healthcare interventions for
managing patients receiving palliative care in the form of
cost-utility analysis.
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Descriptive Statistics of Datasets
Dataset 1: a cancer mortality follow-back survey
(N = 596) from 2009 to 2010 in London (The QUALY-
CARE study).
Dataset 2: a cross-sectional study on symptom burden and
palliative care needs in chronic obstructive pulmonary
disease and cancer in Germany (N = 109).
Dataset 3: a study of Parkinson’s disease (longitudinal
community study of predictive factors; N = 82).
Dataset 4: a randomised phase II trial of dignity therapy
(N = 45, UK).
Dataset 5: a longitudinal study on trajectories of illness of
stage 5 chronic renal disease (N = 74, UK).
Table 7 Descriptive statistics
for development and validation
datasets
Characteristic Development (N = 504) Validation (N = 508)
Female 53% 52%
Male 47% 48%
Age\60 years 16% 12%
Age[60 years 84% 88%
Cancer 79% 77%
Non-cancer 21% 23%
Mean total POS score 13.03 13.14
POS Palliative Care Outcome Scale
Table 8 Rotated three-
component matrixa (N = 504)
Item Component Conceptual domain of item
1 2 3
Anxiety 0.764 Psychological wellbeing
Depression 0.707 Psychological wellbeing
Feeling good 0.645 0.207 –0.265 Psychological wellbeing
Family anxiety 0.625 –0.305 Psychological wellbeing
Pain 0.600 0.259 Physical
Symptoms 0.543 0.309 0.327 Physical
Information 0.755 Quality of care
Practical matters 0.211 0.697 Quality of care
Share feelings 0.240 0.283 –0.667 Psychological wellbeing
Time wasted 0.602 Quality of care
Extraction method: principal component analysis. Rotation method: varimax with Kaiser normalization.
Bold formatting indicates loadings C|0.400|
a Rotation converged in five iterations
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Dataset 6: an RCT on the effectiveness of an integrated
palliative and respiratory care service for patients with
advanced disease and refractory breathlessness in the UK
in 2014 (N = 105).
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